Advanced Biomed investor reports 7.5% passive stake

Advanced Biomed Inc. (ADVB) has a Schedule 13G reporting that Advance On Ventures Limited and Chen Yi Lee are passive beneficial owners of its common stock.

Available on EDGAR 09/22/2026 - 07:55 AM EDT Accepted by SEC EDGAR 09/22/2026 - 07:54 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Advanced Biomed Inc. (ADVB) has a Schedule 13G reporting that Advance On Ventures Limited and Chen Yi Lee are passive beneficial owners of its common stock.

Advance On Ventures Limited beneficially owns 109,200 shares of common stock, representing 6.6% of the class, with sole voting and dispositive power over these shares. Chen Yi Lee beneficially owns a total of 123,840 shares, or 7.5% of the common stock, including the 109,200 shares held by Advance On Ventures Limited, over which he has sole voting and dispositive power, plus 14,640 shares held directly. Percentages are based on 1,652,133 shares outstanding as of May 29, 2026.

Key Figures

Shares outstanding: 1,652,133 shares Advance On Ventures Limited beneficial ownership: 109,200 shares (6.6%) Chen Yi Lee beneficial ownership: 123,840 shares (7.5%) +4 more

7 metrics

Shares outstanding 1,652,133 shares Common stock outstanding as of May 29, 2026 used to compute ownership percentages

Advance On Ventures Limited beneficial ownership 109,200 shares (6.6%) Common stock of Advanced Biomed Inc. with sole voting and dispositive power

Chen Yi Lee beneficial ownership 123,840 shares (7.5%) Includes 109,200 shares held by Advance On Ventures Limited plus 14,640 shares held directly

Direct holdings of Chen Yi Lee 14,640 shares 14,625 shares acquired before the IPO and 15 shares purchased in the open market after the IPO

Par value of common stock $0.001 per share Par value of Advanced Biomed Inc. common stock reported in the filing

Ownership percentage of Advance On Ventures Limited 6.6% Portion of Advanced Biomed Inc. common stock class beneficially owned

Ownership percentage of Chen Yi Lee 7.5% Portion of Advanced Biomed Inc. common stock class beneficially owned

Key Terms

beneficially owned, sole voting power, sole dispositive power, Schedule 13G, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: AOVL is the record holder of 109,200 shares"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 109,200.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 109,200.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13G regulatory

"The response to Row 11 above is based on 1,652,133 shares"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

CUSIP Number financial

"CUSIP Number(s): 00752P203"

A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in ADVB does Advance On Ventures Limited report on this Schedule 13G?

Advance On Ventures Limited reports beneficial ownership of 109,200 shares of Advanced Biomed Inc. common stock, representing 6.6% of the outstanding class, with sole voting and sole dispositive power over all of these shares.

How many ADVB shares does Chen Yi Lee beneficially own according to the Schedule 13G?

Chen Yi Lee beneficially owns 123,840 shares of Advanced Biomed Inc. common stock, representing 7.5% of the class. This includes 109,200 shares held by Advance On Ventures Limited and 14,640 shares held directly by Chen Yi Lee.

What portion of ADVB’s outstanding shares are used to calculate these ownership percentages?

The reported ownership percentages are based on 1,652,133 shares of Advanced Biomed Inc. common stock outstanding as of May 29, 2026, as described in the company’s Definitive Proxy Statement on Schedule 14A filed June 4, 2026.

What voting and dispositive powers do the reporting persons have over ADVB shares?

Advance On Ventures Limited has sole voting power and sole dispositive power over 109,200 shares. Through his role as sole director of that company and his direct holdings, Chen Yi Lee has sole voting and dispositive power over 123,840 shares in total.

What type of security in ADVB is covered by this Schedule 13G?

The Schedule 13G covers Advanced Biomed Inc. common stock, par value $0.001 per share, identified by CUSIP 00752P203.

Where are the reporting persons in the ADVB Schedule 13G organized or citizens of?

Advance On Ventures Limited is organized in the British Virgin Islands, and Chen Yi Lee is a citizen of Taiwan. Both list their principal business address in Yongkang District, Tainan City, Taiwan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Advanced Biomed Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

00752P203

(CUSIP Number)

03/06/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 00752P203

1

Names of Reporting Persons

ADVANCE ON VENTURES Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

VIRGIN ISLANDS, BRITISH

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 109,200.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 109,200.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

109,200.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.6 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: The response to Row 11 above is based on 1,652,133 shares of Common Stock of the Issuer outstanding as of May 29, 2026, as reported in the Definitive Proxy Statement on Schedule 14A filed by the Issuer with the SEC on June 4, 2026.

SCHEDULE 13G

CUSIP Number(s): 00752P203

1

Names of Reporting Persons

LEE CHEN YI

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

TAIWAN

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 123,840.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 123,840.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

123,840.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.5 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The number of shares stated above includes 109,200 shares of Common Stock held by Advance On Ventures Limited, over which Chen Yi Lee, as the sole director of Advance On Ventures Limited, has sole voting and dispositive power, and 14,640 shares of Common Stock held directly by Chen Yi Lee. The response to Row 11 above is based on 1,652,133 shares of Common Stock of the Issuer outstanding as of May 29, 2026, as reported in the Definitive Proxy Statement on Schedule 14A filed by the Issuer with the SEC on June 4, 2026.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Advanced Biomed Inc.
(b)	Address of issuer's principal executive offices: No. 689-85 Xiaodong Road, Yongkang District, Tainan, TAIWAN, 710.
Item 2.
(a)	Name of person filing: This statement is being jointly filed by Advance On Ventures Limited (?AOVL?), a British Virgin Islands company, and Chen Yi Lee, an individual (each, a ?Reporting Person?).
(b)	Address or principal business office or, if none, residence: The principal business address of AOVL is No. 689-87 Xiaodong Road, Yongkang District, Tainan City, Taiwan, and the principal business address of Chen Yi Lee is No. 689-87 Xiaodong Road, Yongkang District, Tainan City, Taiwan,
(c)	Citizenship: AOVL was organized in the British Virgin Islands. Chen Yi Lee is a citizen of Taiwan.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP Number(s): 00752P203
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: AOVL is the record holder of 109,200 shares of Common Stock of the Issuer. Chen Yi Lee is the sole director of AOVL and has sole voting and dispositive power over the shares held by AOVL. Chen Yi Lee also directly holds 14,640 shares of Common Stock, consisting of 14,625 shares acquired prior to the Issuer?s initial public offering and 15 shares purchased in the open market after the initial public offering.
(b)	Percent of class: See Row 11 of the cover page for each Reporting Person.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of the cover page for each Reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of the cover page for each Reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of the cover page for each Reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of the cover page for each Reporting Person.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ADVANCE ON VENTURES Ltd

Signature:	Chen Yi Lee
Name/Title:	Director
Date:	09/21/2026

LEE CHEN YI

Signature:	Chen Yi Lee
Name/Title:	Individual
Date:	09/21/2026

Exhibit Information

Exhibit 1 - Joint Filing Agreement